Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Int J STD AIDS ; 32(14): 1318-1325, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34392724

RESUMO

BACKGROUND: Chlamydia trachomatis (CT) can infect the anorectum producing various signs and symptoms. There is scarce literature regarding the differences between LGV and non-LGV CT anorectal manifestations. We compare the clinical spectrum of LGV and non-LGV infections. METHODS: Patients over 18 years with presumptive infectious anorectal symptoms were examined in two healthcare centres in Buenos Aires. The patients were studied and treated according to current sexually transmitted infection guidelines. Anorectal swabs were collected to detect and genotype CT. RESULTS: A three-year-long study on 317 patients with anorectal symptoms showed 45.11% CT infection (85% LGV strains). Of 140 samples, 92 were sequenced: 80/119 LGV (L2b 45%, L1 32.5% and L2 22.5%) and 12/21 non-LGV. Older age and HIV+ status were significantly higher in the LGV group. Anal discharge, bleeding, severe proctitis and anal ulcers were more common in the LGV group. Multivariate logistic regression analysis revealed that HIV infection, anorectal bleeding and oro-anal sex are independent predictors of LGV infection. CONCLUSIONS: In patients with anorectal symptoms, LGV serovars predominate over non-LGV ones. Clinical manifestations are not pathognomonic of a specific biovar. If genotyping is not available, having clinical predictors may help to presume an LGV infection and define length of treatment.


Assuntos
Infecções por HIV , Linfogranuloma Venéreo , Argentina/epidemiologia , Chlamydia trachomatis/genética , Homossexualidade Masculina , Humanos , Linfogranuloma Venéreo/diagnóstico , Masculino , Sorogrupo
2.
Rev. argent. microbiol ; 49(4): 315-319, Dec. 2017. map, tab
Artigo em Inglês | LILACS | ID: biblio-1041794

RESUMO

The objective of this study was to estimate the prevalence of Treponema pallidum, Trypanosoma cruzi and Human immunodeficiency virus 1 (HIV-1) in five Amerindian populations of Argentina. A retrospective study was conducted among 857 Amerindian populations (112 Kollas, 298 Mbyá-guaraníes, 79 Sagua Huarpes, 368 Wichis) from 2007 to 2010. Screening and confirmation of T. pallidum, T. cruzi and HIV-1 were performed. T. pallidum and T. cruzi infections were detected in all communities with an overall prevalence rate of 4.2% and 16.8%, respectively. Although HIV was not detected, syphilis and Chagas' disease represent a challenge for the health care system and the reinforcement of public health strategies is necessary considering the socioeconomic isolation of these populations.


El objetivo de este trabajo fue estimar la prevalencia de Treponema pallidum, Trypanosoma cruzi y virus de la inmunodeficiencia humana (HIV-1) en 5 comunidades originarias de Argentina. Para ello, se realizó un estudio retrospectivo en 857 individuos (112 kollas, 298 mbyá-guaraníes, 79 sagua huarpes, 368 wichis) desde el 2007 hasta el 2010. Se realizó el diagnóstico completo para T. pallidum, T. cruzi y HIV-1. En todas las comunidades se confirmaron infecciones por T. pallidum y T. cruzi con una prevalencia total del 4,2 y del 16,8%, respectivamente. Aunque no se detectó HIV-1, sífilis y Chagas, representan un desafío para el sistema de salud, teniendo que reforzarse las estrategias de salud pública teniendo en cuenta el aislamiento socio-económico que sufren estas poblaciones.


Assuntos
Humanos , Indígenas Sul-Americanos , Sífilis , Infecções por HIV , Doença de Chagas , Argentina , Treponema pallidum/isolamento & purificação , Trypanosoma cruzi/isolamento & purificação , Sífilis/etnologia , Sífilis/terapia , Infecções por HIV/etnologia , Infecções por HIV/terapia , Estudos Retrospectivos , HIV-1 , Doença de Chagas/etnologia , Doença de Chagas/terapia
3.
Rev Argent Microbiol ; 49(4): 315-319, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28712508

RESUMO

The objective of this study was to estimate the prevalence of Treponema pallidum, Trypanosoma cruzi and Human immunodeficiency virus 1 (HIV-1) in five Amerindian populations of Argentina. A retrospective study was conducted among 857 Amerindian populations (112 Kollas, 298 Mbyá-guaraníes, 79 Sagua Huarpes, 368 Wichis) from 2007 to 2010. Screening and confirmation of T. pallidum, T. cruzi and HIV-1 were performed. T. pallidum and T. cruzi infections were detected in all communities with an overall prevalence rate of 4.2% and 16.8%, respectively. Although HIV was not detected, syphilis and Chagas' disease represent a challenge for the health care system and the reinforcement of public health strategies is necessary considering the socioeconomic isolation of these populations.


Assuntos
Doença de Chagas , Infecções por HIV , Indígenas Sul-Americanos , Sífilis , Argentina , Doença de Chagas/etnologia , Doença de Chagas/terapia , Infecções por HIV/etnologia , Infecções por HIV/terapia , HIV-1 , Humanos , Estudos Retrospectivos , Sífilis/etnologia , Sífilis/terapia , Treponema pallidum/isolamento & purificação , Trypanosoma cruzi/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...